Koers Zhong Yuan Bio-Technology Holdings Limited
Aandelen
ZHYBF
KYG989A31097
Farmaceutische producten
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
5 USD | 0,00% | -0,40% | +146,31% |
Omzet 2022 | 2,33 mln. 2,18 mln. | Omzet 2023 | 1,66 mln. 1,55 mln. | Marktkapitalisatie | 65,94 mln. 61,68 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -1 mln. -935K | Nettowinst (verlies) 2023 | -2 mln. -1,87 mln. | EV/omzet 2022 | 51,2 x |
Nettoschuld 2022 | 1,55 mln. 1,45 mln. | Nettoschuld 2023 | 1,76 mln. 1,64 mln. | EV/omzet 2023 | 40,7 x |
K/w-verhouding 2022 |
-103
x | K/w-verhouding 2023 |
-29,5
x | Werknemers | 35 |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 35,07% |
1 week | -0,40% | ||
3 maanden | +28,53% | ||
6 maanden | +4,17% | ||
Lopend jaar | +146,31% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Ting Ting Chang
CEO | Chief Executive Officer | 34 | 03-05-17 |
Fung Ming Pang
DFI | Director of Finance/CFO | 53 | 04-05-20 |
Xianyang Chen
CTO | Chief Tech/Sci/R&D Officer | 40 | 01-01-16 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chi Wai Tse
BRD | Director/Board Member | 57 | 01-08-22 |
Ting Ting Chang
CEO | Chief Executive Officer | 34 | 03-05-17 |
Fung Ming Pang
DFI | Director of Finance/CFO | 53 | 04-05-20 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
26-04-24 | 5 | 0,00% | 100 |
24-04-24 | 5 | +11,11% | 277 |
23-04-24 | 4,5 | -10,00% | 200 |
22-04-24 | 5 | -0,40% | 300 |
19-04-24 | 5,02 | +0,40% | 100 |
uitgestelde koers OTC Markets, 26 april 2024 om 16:40 uur
Meer koersenVaira. 1 jan. | Kapi. | |
---|---|---|
+146,31% | 88,5 mln. | |
+25,83% | 661 mld. | |
+27,00% | 566 mld. | |
-6,76% | 352 mld. | |
+20,34% | 332 mld. | |
+3,00% | 283 mld. | |
+13,09% | 231 mld. | |
+5,46% | 200 mld. | |
-9,61% | 195 mld. | |
-6,26% | 145 mld. |